Sign in

CIK 0001022899

  • Non-accelerated filer
  • Smaller reporting company

Protagenic Therapeutics, Inc.\new

Sign in to watch
Ticker
PTIX
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
DE
Entity type
Operating
EIN
061390025
Phone
+1 212-994-8200
Business address
149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
Former names
Atrinsic, Inc., NEW MOTION, INC., MPLC, Inc., MILLBROOK PRESS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2010-06-30 Plotts Thomas Chief Financial Officer Grant or award · Options to Purchase Common Stock +250,000 250,000
2010-03-31 Plotts Thomas Interim CFO Exercise or conversion +25,000 38,337
2010-03-31 Plotts Thomas Interim CFO Shares withheld for taxes −9,718 $0.82 $8K 28,619
2010-03-31 Plotts Thomas Interim CFO Exercise or conversion · Restricted Stock Units −25,000 0
2010-01-29 Plotts Thomas Interim CFO Grant or award · Restricted Stock Units +25,000 25,000

Page 1 of 1 · 5 trades